Clinical implications of transitioning from cytology to human papillomavirus-based cervical cancer screening

Acta Obstet Gynecol Scand. 2021 Mar;100(3):371-372. doi: 10.1111/aogs.14107.

Authors

Anne Hammer^{1

2}, Patti Gravitt³

Affiliations

¹ Department of Obstetrics and Gynecology, Gødstrup Hospital, Herning, Denmark.
² Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
³ Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.

PMID: 33739440
DOI: 10.1111/aogs.14107

No abstract available

Publication types

Editorial

MeSH terms

Cytological Techniques
Early Detection of Cancer
Female
Humans
Mass Screening / trends*
Papillomavirus Infections / diagnosis*
Papillomavirus Infections / virology
Uterine Cervical Dysplasia / diagnosis*
Uterine Cervical Dysplasia / virology
Uterine Cervical Neoplasms / diagnosis*
Uterine Cervical Neoplasms / virology
Vaginal Smears